Numerous studies have showed that aberrant epidermal growth factor receptor (EGFR) pathway is a driving gene of NSCLC cancerogenesis, playing a considerable role in the process of malignancies, such as cell proliferation, differentiation and migration (Doerks et al., 2002; Bardelli et al., 2003). This evidence concerns the gene EGFR and non-small cell lung carcinoma.